{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:47:12Z","timestamp":1790700432971,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.cardfail.2008.08.010","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T09:47:43Z","timestamp":1221558463000},"page":"631-640","source":"Crossref","is-referenced-by-count":147,"title":["The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment"],"prefix":"10.1016","volume":"14","author":[{"given":"Gad","family":"Cotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard C.","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Davison Weatherley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"O'connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry M.","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2008.08.010_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0735-1097(01)01470-X","article-title":"Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction","volume":"38","author":"Al-Ahmad","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.08.010_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-1097(99)00608-7","article-title":"The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction","volume":"35","author":"Dries","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.08.010_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis","volume":"293","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2008.08.010_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.08.010_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","article-title":"Worsening renal function and prognosis in heart failure: systematic review and meta-analysis","volume":"13","author":"Damman","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2008.08.010_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2008.08.010_bib7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/CIRCULATIONAHA.105.610642","article-title":"Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction","volume":"114","author":"Smilde","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2008.08.010_bib8","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurheartj\/ehi859","article-title":"Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH)","volume":"27","author":"Cowie","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2008.08.010_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/jcaf.2002.125289","article-title":"The prognostic importance of different definitions of worsening renal function in congestive heart failure","volume":"8","author":"Gottlieb","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2008.08.010_bib10","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.08.010_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","article-title":"Relationship between heart failure treatment and development of worsening renal function among hospitalized patients","volume":"147","author":"Butler","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2008.08.010_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1152\/physrev.00031.2005","article-title":"Adenosine and kidney function","volume":"86","author":"Vallon","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cardfail.2008.08.010_bib13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.95.6.1363","article-title":"Plasma adenosine levels increase in patients with chronic heart failure","volume":"95","author":"Funaya","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2008.08.010_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cardfail.2007.08.006","article-title":"The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment","volume":"13","author":"Dittrich","year":"2007","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cardfail.2008.08.010_bib15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jacc.2007.07.019","article-title":"The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance","volume":"50","author":"Givertz","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.08.010_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(99)00532-X","article-title":"Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure","volume":"35","author":"Gottlieb","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2008.08.010_bib17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2165\/00003495-200161100-00002","article-title":"Renal effects of adenosine A1-receptor antagonists in congestive heart failure","volume":"61","author":"Gottlieb","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.cardfail.2008.08.010_bib18","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2008.08.010_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.cardfail.2008.08.010_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-3565(25)32898-3","article-title":"Sedative and anticonvulsant effects of adenosine analogs in mouse and rat","volume":"220","author":"Dunwiddie","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2008.08.010_bib21","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1067\/mhj.2003.151","article-title":"Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure","volume":"145","author":"Teerlink","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2008.08.010_bib22","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials","volume":"298","author":"Teerlink","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2008.08.010_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1054\/jcaf.2001.25652","article-title":"Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure","volume":"7","author":"Packer","year":"2001","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cardfail.2008.08.010_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2004.05.006","article-title":"Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study","volume":"11","author":"Packer","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2008.08.010_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1054\/jcaf.2000.20841","article-title":"Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE)","volume":"6","author":"Abraham","year":"2000","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2008.08.010_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejheart.2005.12.003","article-title":"Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE","volume":"8","author":"Cleland","year":"2006","journal-title":"Eur J\u00a0Heart Fail"},{"key":"10.1016\/j.cardfail.2008.08.010_bib27","series-title":"Statistical intervals: a guide for practitioners","author":"Hahn","year":"1991"},{"key":"10.1016\/j.cardfail.2008.08.010_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI8761","article-title":"Adenosine formed by 5\u2019-nucleotidase mediates tubuloglomerular feedback","volume":"106","author":"Thomson","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2008.08.010_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1073858404269112","article-title":"Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies","volume":"11","author":"Boison","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.cardfail.2008.08.010_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuropharm.2004.04.015","article-title":"Adenosine acting via A1 receptors, controls the transition to status epilepticus-like behaviour in an in vitro model of epilepsy","volume":"47","author":"Avsar","year":"2004","journal-title":"Neuropharmacology"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916408009809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916408009809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:14:12Z","timestamp":1738365252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916408009809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1071916408009809"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2008.08.010","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}